Original Article

Neuroprotective effects of volume-regulated anion channel blocker DCPIB on neonatal hypoxic-ischemic injury

Authors: Ammar Alibrahim, Li-yan Zhao, Christine You-jin Bae, Andrew Barszczyk, Christopher Lf Sun, Guan-lei Wang, Hong-shuo Sun
DOI: 10.1038/aps.2012.148


Ammar ALIBRAHIM1, 2, Li-yan ZHAO5, Christine You-jin BAE2, Andrew BARSZCZYK2, Christopher LF SUN2, Guan-lei WANG5, *, Hong-shuo SUN1, 2, 3, 4, *

1Departments of Surgery, 2Physiology and 3Pharmacology, 4Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8; 5Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China

Aim: To evaluate the role of swelling-induced activation of volume-regulated anion channels (VRACs) in a neonatal hypoxic-ischemic injury model using the selective VRAC blocker 4-(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on5-yl) oxobutyric acid (DCPIB).

Methods: Cerebral hypoxic-ischemic injury was induced in 7-day-old mouse pups with Rice-Vannucci method. Prior to the onset of ischemia, the animals were ip administered DCPIB (10 mg/kg). The animals were sacrificed 24 h afterwards, coronal sections of the brains were cut and the areas of infarct were examined using TTC staining and an image-analysis system. Cultured PC12 cells were subjected to oxygen-glucose deprivation (OGD) for 4 h. The cellular viability was assessed using Cell Counting Kit 8. Intracellular chloride concentration [Cl–]i was measured using 6-methoxy-N-ethylquinolinium iodide.

Results: DCPIB-treated mice showed a significant reduction in hemispheric corrected infarct volume (26.65%±2.23%) compared to that in vehicle-treated mice (45.52%±1.45%, P<0.001). DCPIB-treated mice also showed better functional recovery as they were more active than vehicle-treated mice at 4 and 24 h post injury. In cultured PC12 cells, DCPIB (10 μmol/L) significantly reduced OGD-induced cell death. Moreover, DCPIB (20 μmol/L) blocked hypotonic-induced decrease in [Cl–]i in PC12 cells of both control and OGD groups.

Conclusion: The results further support the pathophysiological role of VRACs in ischemic brain injury, and suggest DCPIB as a potential, easily administrable agent targeting VRACs in the context of perinatal and neonatal hypoxic-ischemic brain injury.

Keywords: neonatal stroke; neonatal hypoxic-ischemic injury; neuroprotection; volume-regulated anion channel; chloride channel; ClC-3; DCPIB; oxygen-glucose deprivation; PC12 cell

This work was supported by a Grant-in Aid from Heart and Stroke Foundation of Canada to Hong-shuo SUN, and by a General Program from National Natural Science Foundation of China (No 30873059) to Guan-lei WANG. Ammar ALIBRAHIM is a recipient of the Saudi Arabian Cultural Bureau Scholarship. Christine You-jin BAE is a recipient of Ontario Graduate Scholarship.
* To whom correspondence should be addressed.
E-mail hss.sun@utoronto.ca (Hong-shuo SUN); wangglei@mail.sysu.edu.cn (Guan-lei WANG) Received 2012-05-09 Accepted 2012-09-06

Article Options

Download Citation

Cited times in Scopus